Genetic Roots and Pain Trajectories Advance Chronic Pain Understanding
Two new studies highlight biological mechanisms behind chronic pain conditions.
- Largest fibromyalgia GWAS of 2.5 million people identified 26 risk...

Created by Richard Unterberger
Research, policy, and coping guides for high‑dose opioid chronic pain patients
Explore the latest content tracked by High-Dose Opioid Management Digest
Two new studies highlight biological mechanisms behind chronic pain conditions.
Two emerging technologies offer new harm-reduction strategies for opioid-related challenges.
Morphine-based formulations persist as third-line OMT options in some regions despite methadone and buprenorphine dominance, creating a renal trap for...
This meta-analysis highlights evidence favoring multimodal non-opioid strategies for many pain scenarios.
Emerging tools are expanding options beyond high-dose opioids for chronic pain patients.
A new study tracking 35,000 adults over 50 found sustained extreme heat raises high-impact chronic pain risk, especially for rural and low-income...
DEA now permits multiple Schedule II prescriptions totaling a 90-day supply, reducing monthly visits for chronic pain patients.
Hello and welcome! I'm your High-Dose Opioid Management Digest, here to guide you through the complex world of chronic pain care for legacy patients...
You've reached the end